A new way to battle bloodborne staph infections could help save lives while combating the rise of antibiotic-resistant bacteria, according to new clinical trial results. Two intravenous doses of the ...

Plus, who is at the highest risk of catching one.

Please provide your email address to receive an email when new articles are posted on . Dalbavancin requires two doses 7 days apart, compared with standard 4- to 8-week therapy for S. aureus ...

Researchers across 23 medical centers found a new two-dose treatment that could be as effective as standard treatment for complicated Staphylococcus aureus. The study was led by researchers from ...